Cyproterone acetate is an integral part of hepatic DNA adducts induced by this steroidal drug

Carcinogenesis

Volumn 17, Issue 1, 1996, Pages 167-169

  Topinka, J ^a   Binkova, B ^a   Schwarz, L R ^b   Wolff, T ^b  

^a Business School Ostrava plc   (Czech Republic)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; DNA; PHOSPHORUS 32; STEROID; TRITIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA DETERMINATION; DRUG DNA INTERACTION; FEMALE; GENOTOXICITY; ISOTOPE LABELING; LIVER CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY;

ANDROGEN ANTAGONISTS; ANIMALS; CYPROTERONE ACETATE; DNA ADDUCTS; FEMALE; LIVER; RATS; RATS, WISTAR;

EID: 0030007103     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.1.167     Document Type: Article

References (13)

1. Topinka,J., Andrae,U., Schwarz,L.R. and Wolff,T. (1993) Cyproterone acetate generates DNA adducts in rat liver and in primary hepatocyte cultures. Carcinogenesis, 14, 423-427.
2. Neumann,I., Thierau,D., Andrae,U., Greim,H. and Schwarz,L.R. (1992) Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in γ-glutamyltranspeptidase-positive cells. Carcinogenesis, 13, 373-378.
3. 32P-postlabelling analysis of aromatic carcinogen adducts. Cancer Res., 45, 5656-5662.
4. Liehr,J.G., Avitts,T.A., Randerath,E. and Randerath,K. (1986) Estrogen-induced endogenous DNA adduction: possible mechanisms of hormonal cancer. Proc. Natl Acad. Sci. USA, 83, 5301-5305.
5. Schwarz,L.R. and Watkins,J.B. (1992) Uptake of taurocholate, a vecuronium like organic cation, ORG 9426, and ouabain into carcinogen-induced diploid and polyploid hepatocytes obtained by centrifugal elutriation. Biochem. Pharmacol., 43, 1195-1201.
6. Gupta,R.C. (1984) Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl Acad. Sci. USA. 81, 6943-6947.
7. Ducore,J.M. (1988) EDTA alkaline elution characteristics and measurement of DNA damage in unlabeled DNA using Hoechst 33258 fluorescence. Environ. Mol. Mutagenesis, 11, 449-460.
8. 32P-Postlabeling analysis of DNA adducts in rats during estrogen-induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct level. Jpn J. Cancer Res., 83, 438-444.
9. Williams,G.M., latropoulos,M., Cheung,R., Radi,L. and Wang,C.X. (1993) Diethylstilbestrol liver carcinogenicity and modification of DNA in rats. Cancer Lett., 68, 193-198.
10. Bhat,H.K., Han,X.L., Gladek,A. and Liehr,J.G. (1994) Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure. Carcinogenesis, 15, 2137-2142.
11. Caviezel,M., Lutz,W.K., Minini,U. and Schlatter,C. (1984) Interaction of estrone and estradiol with DNA and protein of liver and kidney in rat and hamster in vivo and in vitro. Arch. Toxicol., 55, 97-103.
12. Topinka,J., Binkova,B., Zhu,H.K., Andrae,U., Neumann,I., Schwarz,L.R., Werner,S. and Wolff,T. (1995) DNA-damaging activity of the Cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver. Carcinogenesis, 16, 1483-1487.
13. Schwarz,L.R., Wemer,S., Topinka,J., Andrae,U. and Wolff,T. (1995) The liver as origin and target of reactive intermediates exemplified by the progesterone derivative, Cyproterone acetate. In Snyder,R. and Greim,H. (eds), Proc. 5th Int. Meeting on Biological Reactive Intermediates. Plenum Press, New York, in press.